It is regrettable that KT Dodge links to our post as evidence of the NHS garnering “very poor reviews”. The post in question is a report of a talk given by Professor Michel Coleman on variance of cancer rates across the European Union. From a UK perspective, this is a picture that has been improving steadily as the effects of the NHS Cancer Plan and the Cancer Reform Strategy kick in.
Admittedly, there are still areas of concern for the UK cancer community – and the variance of cancer outcomes according to socioeconomic status is one such area. However, this variance is certainly not unique to the UK, and hard to see how this can be laid at the door of ‘socialised medicine’ per se – the US has similar health inequalities after all.





